Found: 19
Select item for more details and to access through your institution.
Detection of a GLIS3 fusion in an infant with AML refractory to chemotherapy.
- Published in:
- Cold Spring Harbor Molecular Case Studies, 2022, v. 8, n. 5, p. 1, doi. 10.1101/mcs.a006220
- By:
- Publication type:
- Article
UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-39591-2
- By:
- Publication type:
- Article
An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer.
- Published in:
- Nature Communications, 2017, v. 8, n. 2, p. 14294, doi. 10.1038/ncomms14294
- By:
- Publication type:
- Article
Developing a collaborative international partnership for cancer control in Mexico.
- Published in:
- Salud Pública de México, 2022, v. 64, n. 1, p. 100, doi. 10.21149/12506
- By:
- Publication type:
- Article
A 3D Osteosarcoma Model with Bone‐Mimicking Cues Reveals a Critical Role of Bone Mineral and Informs Drug Discovery.
- Published in:
- Advanced Healthcare Materials, 2022, v. 11, n. 17, p. 1, doi. 10.1002/adhm.202200768
- By:
- Publication type:
- Article
Ganciclovir-induced mutations are present in a diverse spectrum of post-transplant malignancies.
- Published in:
- Genome Medicine, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13073-022-01131-w
- By:
- Publication type:
- Article
Pre‐and post‐HSCT use of TKI therapy for fusion‐driven B‐ALL: A case series of five pediatric, adolescent and young adult patients.
- Published in:
- Cancer Reports, 2023, v. 6, n. 12, p. 1, doi. 10.1002/cnr2.1901
- By:
- Publication type:
- Article
Residual Tumor Cells That Drive Disease Relapse after Chemotherapy Do Not Have Enhanced Tumor Initiating Capacity.
- Published in:
- PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0045647
- By:
- Publication type:
- Article
Provocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology Group.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task Force.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Improvement in treatment abandonment in pediatric patients with cancer in Guatemala.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Single-cell analysis of hepatoblastoma identifies tumor signatures that predict chemotherapy susceptibility using patient-specific tumor spheroids.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32473-z
- By:
- Publication type:
- Article
Blocking NRG1 and Other Ligand-Mediated Her4 Signaling Enhances the Magnitude and Duration of the Chemotherapeutic Response of Non-Small Cell Lung Cancer.
- Published in:
- Science Translational Medicine, 2013, v. 5, n. 171, p. 1, doi. 10.1126/scitranslmed.3004438
- By:
- Publication type:
- Article
Long noncoding RNA EWSAT1-mediated gene repression facilitates Ewing sarcoma oncogenesis.
- Published in:
- Journal of Clinical Investigation, 2014, v. 124, n. 12, p. 5275, doi. 10.1172/JCI72124
- By:
- Publication type:
- Article
Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human models.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Statistical algorithms improve accuracy of gene fusion detection.
- Published in:
- Nucleic Acids Research, 2017, v. 45, n. 13, p. 1, doi. 10.1093/nar/gkx453
- By:
- Publication type:
- Article
Synthetic Vulnerabilities in the KRAS Pathway.
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 2837, doi. 10.3390/cancers14122837
- By:
- Publication type:
- Article
Oncoprotein-specific molecular interaction maps (SigMaps) for cancer network analyses.
- Published in:
- Nature Biotechnology, 2021, v. 39, n. 2, p. 215, doi. 10.1038/s41587-020-0652-7
- By:
- Publication type:
- Article
Hydra: A mixture modeling framework for subtyping pediatric cancer cohorts using multimodal gene expression signatures.
- Published in:
- PLoS Computational Biology, 2020, v. 16, n. 4, p. 1, doi. 10.1371/journal.pcbi.1007753
- By:
- Publication type:
- Article